You can alphabetize data in an Excel spreadsheet by row or column using the "Sort" feature, or through the "Data" and "Home" tabs.

We'll likely have to wait a while to see Firefly Aerospace's Alpha rocket take to the skies again. The first stage of the rocket that Firefly was prepping to make Alpha's seventh-ever flight exploded ...

Former Rep. Adam Kinzinger (Ill.), who is one of Donald Trump’s most outspoken Republican critics, used a weekend thread on Threads to eviscerate what he slammed as the president’s fake tough-guy ...

Alibaba (NYSE:BABA) will integrate Nvidia's (NASDAQ:NVDA) suite of AI development tools for 'Physical AI' into its cloud software platform. Alibaba Cloud’s Platform for AI, or PAI, announced an ...

Doug Clinton, Intelligent Alpha founder and CEO, joins 'Closing Bell' to discuss the excitement around equities, if investors have to take a leap of faith on AI companies and much more. Key takeaways ...

What if we could leave the solar system? In this video, we explore what a journey to Alpha Centauri would look like, how long it would take, and what we might discover when we arrive. White House ...

This post is for anyone who feels so motivated to achieve their goals that it sometimes turns into paralyzing pressure, making it impossible to relax. Imagine this scenario: Nicola is an athlete who ...

The U.S. Federal Aviation Administration (FAA) has cleared Firefly Aerospace to resume launches of its Alpha rocket. The approval follows a months-long review of the failed "Message in a Booster" ...

Upexi Inc. (NASDAQ:UPXI) reported its Solana (CRYPTO: SOL/USD) treasury reached $447 million as of Sept. 10, with unrealized gains totaling $142 million. The Tampa-based consumer products and ...

System76's COSMIC desktop will soon be in beta. Even as an alpha release, COSMIC is impressive. COSMIC is as fast as any Linux desktop I've experienced. Alpha releases aren't to be used for any reason ...

Loeb does a pretty good job with everything in the issue. The continuity wonk inside of me is kind of mad that continuity for an alternate universe isn’t being followed, but the rest of the story ...

Novartis is taking another shot at alpha-synuclein as a target for treating Parkinson’s disease via a $200 million upfront licensing deal with Arrowhead Pharmaceuticals. The Swiss pharma plans to use ...